USP Zdrowie

What USP Zdrowie does

USP Zdrowie sp. z o.o. is the leading over-the-counter (OTC) pharmaceutical company in Poland, founded in 1992 by Voitka Napiórkowski and headquartered in Warsaw at ul. Poleczki 35. The company operates as the principal OTC subsidiary of USP Group, a diversified Polish pharmaceutical conglomerate that also controls US Pharmacia (manufacturing), EU Pharmacia, Spark and Mortar, and Healthily. With roughly 600 employees and a portfolio of 40 brands, USP Zdrowie holds the #1 position in Polish OTC and counts Ibuprom, APAP, and Gripex among the top five OTC brands nationally. The company combines a long-tenured brand portfolio with proprietary ingredient platforms such as VERISOL bioactive collagen peptides (in Remé), Multilac synbiotic formulations, and ActiBPF bergamot polyphenol extracts (in Berimal), augmented by consumer-target launches including bonevum (osteoporosis, launched August 2025) and the Trilac acquisition (April 2026).

The business monetizes through one-time product sales of OTC medicines, dietary supplements, and medical devices across pain relief, cold/flu, digestive, allergy, women's health, pediatric, and supplement categories. Go-to-market is sales-led via direct relationships with pharmacy chains, retail outlets, and an in-house pharmaceutical warehouse near Wrocław, supplemented by a dedicated pharmacist portal (Stworzone dla Farmaceuty), national TV advertising (e.g., bonevum 8M+ viewer reach), digital personalization stacks, and educational campaigns such as the Świadoma Suplementacja initiative. The customer base is horizontal: Polish consumers seeking self-care, plus pharmacists and physicians as recommendation-driven gatekeepers; downstream pharmacy and retail channels translate shelf demand into revenue. Pricing is set through retailers and is not publicly disclosed, consistent with mass-market consumer healthcare economics.

Strategically, the company pursues portfolio widening through organic launches (bonevum, Glukelo, Magnokal, Noko, Proktosedon, Ummu) and selective M&A (Trilac), while extending its stakeholder reach via the Fundacja Hello Zdrowie foundation (established April 2025) and academic partnerships with institutions such as Warsaw Medical University. The firm is privately held within USP Group, with no external PE/VC investors disclosed; share capital is reported at 25,610,250 PLN. Operational footprint is single-country/domestic (Poland), with an export email channel suggestive of nascent international activity but no confirmed material overseas revenue.

Name

USP Zdrowie

Legal name

USP Zdrowie sp. z o.o.

Website

https://uspzdrowie.pl

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

501–1,000 employees

Short description

USP Zdrowie is Poland's #1 over-the-counter pharmaceutical company with a portfolio of 40 brands including Ibuprom, APAP, and Gripex, serving Polish consumers through pharmacy and retail channels as the OTC subsidiary of USP Group.

Ownership category

akta.pro rank

Product category

OTC Pharmaceuticals (Consumer Healthcare)

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (4242), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC)

akta.pro secondary industries

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE), Sleep, Stress & Mood OTC (Sleep Aids, Melatonin OTC, Calm/Stress Relief) (CRADAMAJ), Allergy, Sinus & Respiratory (Non-Asthma) (HLAIADAC)

Keywords

• OTC pharmaceuticals
• Consumer healthcare products
• Pharmacy distribution
• Dietary supplements
• OTC medicines

Headquarters

HQ city

Warsaw

HQ country

Poland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D

Revenue model

1. OTC Pharmaceutical Products Sales: USP Zdrowie generates revenue through the sale of over-the-counter medicines, dietary supplements, and health products across their portfolio of 40+ brands including Ibuprom, Apap, Gripex, and others. Products are sold through pharmacy chains, retail stores, and direct-to-consumer channels in Poland.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

USP Zdrowie markets and distributes a portfolio of over 40 over-the-counter (OTC) pharmaceutical brands, dietary supplements, and medical devices sold without prescription through pharmacy chains and retail stores across Poland. Products span pain relief, cold and flu, allergy, digestive health, probiotics, vitamins and supplements, women's health, children's health, urinary tract, bone health, and sleep support under brands including Apap, Ibuprom, Gripex, Acatar, Aleric, Stoperan, Xenna, Verdin, Multilac, Naturell, Pelavo, Vigor, Remé, Bonevum, and others.

Product overview

USP Zdrowie is a pharmaceutical company and the #1 OTC (over-the-counter) market leader in Poland for over 30 years, operating as part of USP Group. The company offers a broad portfolio of non-prescription medicines, dietary supplements, medical devices, and health products organized across multiple therapeutic categories: pain relief (Apap, Ibuprom, Difortan, Ultrapiryna, Naxii), cold and flu (Gripex, Acatar, Aleric, Pelavo, Contril, Gripactive, Honikan, Herbitussin), digestive health (Stoperan, Xenna, Verdin, Manti, Hepatil, Recenum), probiotics and supplements (Multilac, Estabiom, Naturell, Vigor, Iskial, Berimal), women's health (Jasnum, Pueria, Clotidal, Remé), allergy (Aleric), urinary tract (Furaginum), and sleep (Sentino). Recent additions include Bonevum for osteoporosis (2025) and Trilac probiotic (acquired 2026). The company also maintains dedicated platforms for pharmacists (Stworzone dla Farmaceuty) and consumer education campaigns.

Differentiator

Problem solved

Functional benefit

Brands

• Apap: Most recognizable pain relief brand in Poland, existing for over 30 years. Contains paracetamol for pain and fever relief.
• Ibuprom
• Gripex
• Acatar
• Aleric
• Artresan
• Berimal
• Bonevum
• Clotidal
• Contril
• Difortan
• Estabiom
• Furaginum US Pharmacia
• Gripactive
• Hepatil
• Herbitussin
• Honikan
• Inovox
• Iskial
• Jasnum
• Manti
• Multilac
• Naturell
• Naxii
• Oryal
• Pelavo
• Pueria
• Recenum
• Remé
• Sentino
• Stoperan
• Ultrapiryna
• Verdin
• Vigor
• Xenna
• Trilac

Products and services

• Apap Poland's most recognizable OTC paracetamol-based pain and fever relief brand, containing paracetamol. The company's original brand since 1992; addresses pain, fever, headache, and related symptoms. Sold through pharmacy and retail channels without prescription.
• Ibuprom Largest OTC brand in Poland offering ibuprofen-based medicines for pain, inflammation, and fever relief across headaches, back pain, menstrual pain, and toothaches. Sold through pharmacy and retail channels.
• Gripex Market leader in cold and flu treatments in Poland, offering tablet, sachet, and innovative 2-in-1 dissolvable/coated tablet formulations addressing multiple cold and flu symptoms. Sold through pharmacy and retail channels.
• Acatar Most recognizable Polish brand for nasal congestion, offering preparations for easier breathing across multiple dosage forms. Sold through pharmacy and retail channels.
• Aleric Leading OTC allergy treatment brand offering antihistamine tablets with desloratadine (including orally disintegrating tablets), syrup for adults and children from age 6, and a mometasone nasal spray. Sold through pharmacy and retail channels.
• Stoperan Market leader in diarrhea treatment in Poland for nearly 20 years. Provides acute and chronic diarrhea treatment; recommended by the World Gastroenterology Organization. Sold through pharmacy and retail channels.
• Xenna Poland's best-known and most popular constipation relief brand for nearly 30 years, available in multiple dosage forms for adults and children. Sold through pharmacy and retail channels.
• Verdin Poland's #1 digestive health brand for nearly 20 years. Only brand offering digestive products in 4 forms: tablets, capsules, drops, and teas. Verdin Max achieved the #1 position in the digestive capsules segment within 2 years of launch. Sold through pharmacy and retail channels.
• Multilac Leading Polish probiotic brand. All products are synbiotics combining beneficial bacterial strains with prebiotics to regenerate and rebuild intestinal microbiome. Range covers adults, seniors, and children. Sold through pharmacy and retail channels.
• Naturell One of the leading supplement brands in Poland, with a wide range of vitamins, minerals, plant-based ingredients, and Omega 3 fatty acids. Sold through pharmacy and retail channels.
• Vigor One of Poland's most recognizable multivitamin brands, known for comprehensive compositions supporting daily health and wellbeing. Sold through pharmacy and retail channels.
• Pelavo Brand combining natural plant extracts with current medical knowledge for children's cold treatments; 9 variants for different children's age groups. Most recognizable pediatric brand in the USP Zdrowie portfolio, present in Poland for over 10 years. Sold through pharmacy and retail channels.
• Artresan Joint health brand present in the Polish market for over 20 years. Wide product range including Artresan Efekt with ApresFlex and Artresan Optima with glucosamine. Sold through pharmacy and retail channels.
• Inovox OTC throat lozenges brand present on the Polish market for nearly 10 years. Inovox Express combines 3 active ingredients targeting viruses, bacteria, and fungi; Inovox Ultra contains flurbiprofen for strong anti-inflammatory action. Sold through pharmacy and retail channels.
• Honikan Honey-based medical devices for cough and sore throat, plus a dietary supplement for immunity and energy containing real honey. Launched in the 2022/2023 season. Sold through pharmacy and retail channels.
• Clotidal Brand for treating intimate infections, including Clotidal MAX (positioned for intimate infection treatment) and Clotidal cream. Product line offers treatment options for both women and men. Sold through pharmacy and retail channels.
• Jasnum Brand addressing diverse needs of women during menopause with supplements and medical devices, targeted at modern women aged 45+. Sold through pharmacy and retail channels.
• Pueria Brand for women planning motherhood, during pregnancy, and while breastfeeding. Supplements feature clean compositions without fillers, artificial colors, or synthetic preservatives; developed per Polish Gynecologists' guidelines. Sold through pharmacy and retail channels.
• Remé Collagen beauty formula combining VERISOL bioactive collagen peptides with vitamins and minerals to support skin, hair, and nail health from within. Awarded "Cosmetic of All Time" by Wizaż.pl in the dietary supplements category. Sold through pharmacy, retail, and the dedicated brand website.
• Furaginum US Pharmacia Brand for urinary tract infections, treating acute and recurrent lower urinary tract infections by inhibiting bacterial growth and multiplication. Sold through pharmacy and retail channels.
• Difortan Topical analgesic gel containing etofenamate with high bioavailability for pain and inflammation relief. Sold through pharmacy and retail channels.
• Manti Heartburn brand on the Polish market for nearly 30 years, with the Manti Extra innovation offering improved patient care for heartburn symptoms. Sold through pharmacy and retail channels.
• Hepatil Brand supporting liver health. Recognized as "Debiut" (new product debut) in the expert category at the DOZ.PL 2025 Znakomitość Roku awards. Sold through pharmacy and retail channels.
• Recenum Acute diarrhea medication for children containing racecadotril; recommended by ESPGHAN. First OTC racecadotril medication for children, enabling home treatment and reducing diarrhea duration and dehydration risk. Sold through pharmacy and retail channels.
• Iskial Products based on shark liver oil with supplements containing vitamin D, garlic, zinc, and vitamin C, supporting immune function for the whole family. Sold through pharmacy and retail channels.
• Estabiom Line of probiotic preparations containing Lactobacillus rhamnosus GG strain for children and women, particularly during pregnancy and breastfeeding. Sold through pharmacy and retail channels.
• Oryal Major player in the Polish electrolytes market for over 6 years; products containing sodium, potassium chloride, magnesium, and calcium to support proper body hydration. Sold through pharmacy and retail channels.
• Contril Syrup for suppressing dry, persistent cough, for children above 2 years and adults. Joined the USP Zdrowie portfolio in 2023 as a complement to existing cough and cold products. Sold through pharmacy and retail channels.
• Gripactive Dietary supplement sachets combining popular natural plant extracts (elderberry, Andrographis paniculata, Iceland moss) with vitamin C for cold and flu support. Sold through pharmacy and retail channels.
• Herbitussin Dietary supplement lozenges inspired by nature, combining traditional ingredients (eucalyptus, marshmallow, thyme, vitamin C, essential oils) with the latest scientific findings. Sold through pharmacy and retail channels.
• Naxii OTC medication based on naproxen sodium for pain reduction, fever reduction, and inflammation suppression, indicated for joint, back, and muscle pain. Sold through pharmacy and retail channels.
• Berimal First Polish brand to offer dietary supplements containing ActiBPF — a unique standardized bergamot polyphenol composition — for cholesterol management. Sold through pharmacy and retail channels.
• Sentino Product supporting good sleep and sleep hygiene, featuring accompanying patient education materials (sleep hygiene guide, patient brochure). Sold through pharmacy and retail channels.
• Bonevum Medication with calcium and vitamin D supplementing osteoporosis therapy, dedicated primarily to women with decreased bone density after age 45. Launched in August 2025 with a nationwide Polish television campaign. Sold through pharmacy and retail channels and promoted via the dedicated bonevum.pl website.
• Trilac Probiotic medication acquired by USP Group in April 2026, present on the Polish market for 25 years. Strengthens USP Zdrowie's position in the Polish probiotics market alongside Multilac. Sold through pharmacy and retail channels.
• Ultrapiryna OTC aspirin-based pain medication brand existing on the Polish market for years. Sold through pharmacy and retail channels.
• Glukelo Brand listed in the USP Zdrowie portfolio. Sold through pharmacy and retail channels.
• Magnokal Brand listed in the USP Zdrowie portfolio, supporting vitality and immune function. Sold through pharmacy and retail channels.
• Noko Brand listed in the USP Zdrowie portfolio. Sold through pharmacy and retail channels.
• Proktosedon Brand listed in the USP Zdrowie portfolio. Sold through pharmacy and retail channels.
• Ummu Brand listed in the USP Zdrowie portfolio. Sold through pharmacy and retail channels.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration16 records

AI capability2 records

Feature2 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Dietetyka #NieNaŻartycoreStrategic or Co-development PartnerPartnership for nationwide educational campaign 'Świadoma Suplementacja' with tagline 'Mniej, ale lepiej'. The campaign aims to organize knowledge about supplementation and restore its proper context: moderation, facts, and real body needs.
• Warsaw Medical University (WUM) - Faculty of PharmacyminorStrategic or Co-development PartnerLong-term partnership supporting young scientists through prizes in the Master's Thesis Competition for the Faculty of Pharmacy. Competition plays important role in academic and professional community, with many results becoming basis for future scientific publications.
• Fundacja Hello ZdrowiecoreStrategic or Co-development PartnerFoundation established by USP Zdrowie in April 2025 to focus on health prevention education with special emphasis on women's health, undertaking numerous social and educational initiatives. Foundation connects various environments including associations, NGOs, public institutions, and specialists.
• DOZ.PLminorGTM or Marketing PartnerAnnual ZNAKOMITOŚĆ ROKU awards recognizing brands trusted by experts and consumers. USP Zdrowie brands MULTILAC and HEPATIL received recognition in 2025.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Regional players

• Zentiva: Central-European generics and OTC company headquartered in Prague with significant CEE market presence, overlapping USP Zdrowie's OTC and supplement categories across Central and Eastern European pharmacy channels.
• Omega Pharma: European OTC specialist with a large pan-European generics-brand portfolio (pain, cold, dermatology) competing with USP Zdrowie's OTC franchises across multiple European markets though it is not a focused Polish player.

Broad incumbents

• Teva Pharmaceutical Industries: Global generics and OTC manufacturer with consumer health brands across pain, cold/flu and women's health categories that overlap with USP Zdrowie's broad 40-brand OTC and supplement portfolio on Polish shelves.
• Stada Arzneimittel: European OTC and generics specialist with broad pain, cold/flu, probiotic and supplement brands that competes with USP Zdrowie's portfolio across Central Europe, including Poland, in similar OTC/CHC channels.
• Bayer Consumer Health: Global OTC major with Aspirin, Bepanthen and Berocca competing in pain relief, dermatology and supplements against USP Zdrowie's Ultrapiryna, Difortan and Naturell/Vigor brands in the Polish market.
• Reckitt Benckiser Group: Global OTC consumer health major whose Nurofen (ibuprofen) and Strepsils brands directly compete with USP Zdrowie's Ibuprom and Inovox franchises in Poland, while the broader portfolio (Dettol, Gaviscon) competes across adjacent OTC categories.
• Sanofi Consumer Healthcare: Global OTC player with Dulcolax, Allegra and Mucosolvan competing in digestive, allergy and respiratory OTC categories — direct analogues to USP Zdrowie's Xenna, Aleric and Herbitussin/Honikan brands in Poland.

Direct peers

• Polpharma: Poland's largest domestic pharmaceutical manufacturer and one of the closest direct peers to USP Zdrowie, operating across OTC and Rx categories with leading pain-relief and cold/flu brands that compete head-to-head with Ibuprom, Apap and Gripex on Polish pharmacy shelves.
• Aflofarm Farmacja Polska: Largest Polish OTC and dietary supplement manufacturer with a multi-brand portfolio directly comparable to USP Zdrowie's 40-brand structure, competing in pain relief, cold/flu, vitamins and women's health categories on the same Polish pharmacy distribution channels.
• HASCO-LEK: Polish pharmaceutical company producing OTC medicines and dietary supplements distributed through Polish pharmacies and retail, with a brand portfolio that overlaps substantially with USP Zdrowie's core categories (pain, cold/flu, supplements).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/uspzdrowie
• Facebookfacebook.com/uspzdrowie
• LinkedInlinkedin.com/company/usp-zdrowie

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about USP Zdrowie